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Abstract 
BACKGROUND: Postmenopausis is a period that begins one year after the last menstrual period. Abnormal 
uterine bleeding could be of different origins. 
AIM: This study aimed to determine the association of serum estrogen hormone levels and obesity with the 
occurrence of endometrial bleeding in post-menopausal women. 
MATERIAL AND METHODS: Prospective clinical study involving 120 postmenopausal patients treated at the 
University Clinic for Gynecology and Obstetrics-Skopje, divided into two groups: control and study. The control 
group consisted of 40 postmenopausal patients without endometrial bleeding, hospitalised and operated due to 
urogenital pathology. The study group consisted of 80 patients with endometrial bleeding who were divided into 
three subgroups according to the thickness of the endometrium: from 5-8 mm, 8-11 mm and above 11 mm. In all 
subjects, estradiol and BMI was determined. 
RESULTS: Estradiol levels were statistically higher in the study group compared to control while statistically 
significant difference among the three subgroups according to the thickness of the endometrium about the levels 
of estradiol in blood is not found. About BMI, the results showed that there was no statistical significance between 
the two examined groups. 
CONCLUSION: Patients with endometrial bleeding have increased levels of estradiol and are at increased risk of 
endometrial cancer about controls, the likelihood of endometrial cancer significantly increases by 1,108 times. 
 
 
 
 
 
 
Introduction 
 
Over the last 30 years, there has been an 
increased incidence of endometrial malignancy in the 
world, and especially in highly developed countries. 
The incidence of postmenopausal women is the 
highest with a peak of 85% in the age group 55-63 [1], 
[2]. Postmenopausis is a period that starts one year 
after the last menstrual period. It is divided into early 
and late menopause. Late menopause, after 70 years, 
is called senile. Almost 5% of all the visits by a 
gynaecologist are due to postmenopausal bleeding 
[3]. During this period, abnormal uterine bleeding may 
range from polyps, endometrial atrophy, endometrial 
hyperplasia, endometrial cancer, submucosal fibroid, 
hormone therapy, uterine infections or cervix, use of 
certain medications such as blood thinners [4], etc. In 
most cases, endometrial bleeding is associated with 
endometrial polyps (6% of cases) [5] or endometrial 
atrophy (almost 50% of cases) [6]. Studies suggest 
that only 3.7%-17.9% of cases with postmenopausal 
bleeding are due to endometrial cancer [7]. 
Ultrasonography is widely used as a 
diagnostic method for evaluating irregular bleeding in 
postmenopausal women [8]. For the time being, there 
is no consensus on the limit value of endometrium 
thickness in which there is no need for sampling for 
analysis in cases of endometrial bleeding [8]. In 
postmenopausal ovaries, they have no more follicles, 
thus stopping the production of estradiol and 
progesterone. The value of oestradiol in 
postmenopausis ranges from 10 to 20 pg/mL. 
According to the results of many studies, oestradiol is 
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a significant predictor of endometrial malignancy and 
endometrial bleeding [8], [9]. According to Naomi's 
study and chronic endometrial malignancy, 
endometrial bleeding in patients in menopause is 
positively associated with an elevated estradiol level 
[9]. 
Obesity is also strongly associated with the 
development of endometrial bleeding [10]. Almost 
57% of endometrial bleeds in the United States are 
due to overweight [11], [12]. The meta-analysis 
involving 26 studies, the American Cancer Research 
Institute, found that an increase in Body Mass Index 
(BMI) by five units increases the risk of endometrial 
bleeding by 50% [13]. The mechanism of action of 
obesity as a risk factor for endometrial bleeding in 
postmenopausal women is explained by the increased 
adiposity that increases the activity of aromatase, 
which leads to the conversion of androgenic 
hormones into estrogens and directly promotes the 
proliferation of endometrium and transcription of the 
pro-proliferative genes. Chronic inflammation 
associated with visceral adiposity is mediated by 
proinflammatory adipokines and leads to 
hyperinsulinemia, to an increase in insulin-like growth 
factor 1 (IGF1) and hyperglycaemia, which increases 
endometrial proliferation. At the same time, reduction 
of anti-inflammatory cytokines was observed. 
Inflammation and an increase in estrogen metabolites 
additionally contribute to DNA damage and genetic 
instability. Finally, stem cells can be recruited from the 
adipose tissue, where they contribute to supporting 
the tumour. The purpose of this study was to 
determine the eventual difference in the level of serum 
estrogen hormones, i.e. obesity in endometrial 
bleeding in postmenopausal women.  
This study aimed to determine the association 
of serum estrogen hormone levels and obesity with 
the occurrence of endometrial bleeding in post-
menopausal women. 
 
 
Material and Methods 
 
This is a prospective clinical study involving 
120 postmenopausal patients treated at the University 
Clinic for Gynecology and Obstetrics-Skopje. Patients 
were divided into two groups: control and examination 
group. The control group included 40 postmenopausal 
patients without endometrial bleeding, hospitalised 
and operated due to urogenital pathology, and with an 
orderly histopathological finding of the material 
obtained with an explorative endometrial curettage. 
The study group included 80 postmenopausal patients 
with endometrial bleeding. According to the ultrasound 
verified thickness of the endometrium, they were 
divided into three subgroups: from 5 -8 mm, 8-11 mm 
and above 11 mm. Each patient was given a detailed 
history, weight and height were determined for BMI 
calculation and 5 mL of venous blood was taken to 
determine the serum estradiol level. This study 
excluded patients who received hormone replacement 
therapy, patients to whom fractional explorative 
curettage cannot be performed, patients with a 
personal history of malignant diseases, benign or 
malignant ovarian changes and patients who were 
operated of breast cancer under treatment with 
tamoxifen. 
The concentration of oestradiol in serum was 
determined by the chemiluminescent method of the 
Immulite 2000 analyser in the biochemical laboratory 
at the University Clinic for Gynecology and Obstetrics 
Skopje. For the reference values of oestradiol in 
postmenopausis, values of 4 to 71.2 pg/mL were 
taken. Ultrasound analysis was performed with an 
ultrasonic device Voluson E8, and the measurement 
was done with a transvaginal probe whereby the 
patients were in the supine position at the 
gynaecological chair. The examination was performed 
on an empty bladder with a probe for each patient 
separately. All the analyses were made in a 
longitudinal section of the uterus, where both the 
cervix and the fundus of the uterus are displayed 
simultaneously, and the endometrial media line is also 
visualized. 
Quite often in the study was voluntary and 
anonymous without any procedures or conditions that 
imply coercion and it was approved by the responsible 
bodies of the Medical Faculty at the Ss Cyril and the 
Methodius University of Skopje, Skopje. 
 
Statistical analysis 
All tests were performed with SPSS 20.0. 
Continuous variables were described using mean and 
standard deviation (SD) or median and interquartile 
range. Categorical variables were described using 
frequencies and percentages. Data were tested for 
normality by Shapiro-Wilk tests and graphically 
checked for symmetry. Differences between groups 
were assessed by Mann-Whitney U tests and Kruskal-
Wallis ANOVA test. P values < 0.05 was set as the 
threshold for statistical significance. 
 
 
Results 
 
The average blood estradiol level among the 
examinees in the sample was 29.8 ± 14.1 pg/ml with a 
minimum value of 20 pg/mL and a maximum value of 
99.5 pg/mL. In the control group, the mean estradiol 
level in the blood was 25.5 ± 12 pg/mL with a 
minimum value of 20 pg/ml and a maximum value of 
80.9 pg/mL. In patients in the test group with 
endometrial bleeding, the mean blood estradiol 
concentration was 31.9 ± 14.7 pg/mL with a minimum 
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value of 20 pg/mL and a maximum value of 99.5 
pg/mL and was significantly elevated relative to the 
control group, p < 0.05 (Mann-Whitney U Test: Z = 
3.9108, p = 0.00009). In 50% of patients in the test 
and control group the blood estradiol value was 
greater than the corresponding IQR = 29 pg/mL (21.9-
34.9) vs. IQR = 20 pg/mL, Table 1 (20-25 pg/mL). 
Table 1: Concentration of serum estradiol (pg/mL) in the 
control and examination group 
Group Number n Mean value SD 
Minimum 
 
Maximum 
 
Mediana IQR 
 
Control 40 25.48 11.98 20 80.9 20 (20-25) 
Examination 80 31.95 14.72* 20 99.5 29 (21.9-34.9) 
Total value 120 29.79 14.15 20 99.5 26 (20-32.7) 
 
According to the division of patients from the 
study group into three subgroups according to the 
thickness of the endometrium, an analysis of blood 
estradiol values was performed in each of these 
groups, Table 2. In the first subgroup, with a thickness 
of endometrium 5-8 mm, blood estradiol was 30 ± 
11.5 pg/mL with a minimum value of 20 pg/mL and a 
maximum value of 66 pg/mL. According to the media 
analysis, 50% of patients in this subgroup had a blood 
estradiol value greater than IQR = 27.1 pg/mL (20.8-
32.5 pg/mL). In the second subgroup with an 
endometrial thickness of 8 mm-11 mm, the mean 
value of oestradiol in the blood accounted for 33.3 ± 
19.2 pg/mL with a minimum value of 20 pg/mL and a 
maximum value of 87 pg/mL. According to the 
analysis of the media, 50% of patients in this 
subgroup had a blood estradiol value greater than 
IQR = 28.8 pg/mL (21.5-36 pg/mL). In the third 
subgroup with a thickness of endometrium > 11mm, 
the mean blood estradiol concentration was 33.6 ± 
15.7 pg/mL with a minimum value of 20 pg/mL and a 
maximum value of 99.5 pg/mL. According to the 
media analysis, 50% of patients in this subgroup had 
a blood estradiol level greater than IQR = 29.6 pg/mL 
(25.4-36.3 pg/mL). Statistical analysis of the results 
showed that there was no significant significance in 
blood concentrations of estradiol in patients with 
different endometrial thickness (Kruskal-Wallis 
ANOVA: H = 1.815984 p = 0.4033), Table 2. 
Table 2: Blood oestradiol concentrations (pg/mL) in patients 
with different endometrial thickness 
Subgroups 
Endometrial 
thickness (mm) 
Number 
N 
Mean 
value 
SD Minimum Maximum Mediana IQR 
5 – 8 36 30.03 11.47 20 66 27.1 (20.8-32.5) 
8 – 11 17 33.35 19.17 20 87 28.8 (21.5-36) 
> 11 27 33.64 15.67 20 99.5 29.6 (25.4-36.3) 
Total value 80 31.95 14.72 20 99.5 29.2 (21.9-34.9) 
 
Within the research, the respondents in the 
whole sample were analysed according to the BMI 
value. The average BMI value in the entire sample 
was 29.2 ± 4.9 kg/m
2
 with a minimum value of 14.9 
kg/m
2
 and a maximum value of 42.7 kg/m
2
, Table 3. 
According to the IQR, 50% of patients in the whole 
sample had BMI with a height greater than 29.3 kg/m
2
. 
 
Table 3: Values for BMI (kg/m
2
) in the control and examination 
group 
Group Number 
Mean 
Value 
Sd Minimum Maximum Mediana IQR 
Examination 80 29.46 5.42 14.9 42.7 29.7 (26-32.3) 
Control 40 28.66 3.85 21.8 41.4 28.2 (26.1-30.3) 
Total value 120 29.19 4.95 14.9 42.7 29.3 (26-32) 
 
The statistical analysis of the BMI results 
showed that there is no statistical significance 
between the two groups of patients. Patients in the 
examined group had an average BMI of 29.5 ± 5.4 
kg/m
2
 with a minimum value of 14.9 kg/m
2
 and a 
maximum of 42.7 kg/m
2
. According to the median 
analysis (IQR), 50% of patients in this group had a 
BMI value greater than 29.7 kg/m
2
. In the control 
group, the average BMI of the patients was 28.7 ± 3.8 
kg/m
2
 with a minimum value of 21.8 kg/m
2
 and a 
maximum value of 41.4 kg/m
2
. According to the 
median (IQR), fifty per cent of the subjects in the 
control group had a BMI value greater than 28.2 
kg/m
2
. 
 
 
Discussion 
 
Estradiol is a significant predictor of 
endometrial malignancy, especially in patients with 
endometrial bleeding. The results of serum estradiol 
levels in this study showed that according to the 
media analysis, 50% of patients in this subgroup had 
an estradiol level greater than IQR = 29.6 pg/mL 
(25.4-36.3 pg/mL), which can be assumed to be at 
increased risk of endometrial cancer. Studies of 
Naomi et al., suggest a positive association between 
endometrial malignancy in postmenopausal patients 
and the level of estradiol [9]. Under the influence of 
relatively high levels of estrogen stimulation, 
postmenopausal endometrium may develop mild 
architectural changes and turn into so-called impaired 
proliferative endometrium [14] or may show an 
increase in degrees of architectural and cytological 
atypia and have a form of atypical endometrial 
hyperplasia (endometrial intraepithelial neoplasia) [15] 
or endometrial intraepithelial carcinoma [16] from 
which endometrial cancer can develop. 
The endometrial carcinoma shows a positive 
association with the increased body mass index, so in 
39% of cases with endometrial cancer is in obese 
women [17]. Several mechanisms can promote 
endometrial cancer or progression in overweight or 
obese women. Primarily, this association can be 
explained by an increase in circulating estrogens 
arising from the aromatisation of androgenic 
precursors in adipose tissue, leading to endometrial 
cell proliferation [18]. The data in the consulted 
literature coincide with the results of this study. Thus, 
in the study of Widderpas et al., [19], it was found that 
the assembled patients with BMI of 30-33.9 kg/m
2 
had 
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a three-fold risk of developing endometrial 
malignancy, which is consistent with the results in this 
study in which the statistical analysis showed that for 
each unit an increase in BMI, the probability of 
endometrial carcinoma increased by 1.484 times (p = 
0.0001, 95% CI = 1.205-1.829). 
In conclusion, concentration of serum 
estradiol in patients with bleeding (31.9 ± 14.7 pg/mL) 
was statistically significantly elevated relative to the 
control group, (25.5 ± 12 pg/mL), p < 0.05. Among the 
subgroups of patients with different endometrial 
thickness, statistical significance for the concentration 
of oestradiol in serum was not found. No statistical 
significance was found for the values of the body 
mass index between the control group (28.7 ± 3.8 
kg/m
2
) and the test group (29.5 ± 5.4 kg/m
2
), but the 
values are in between obesity and obesity. If it is 
known that increased body mass, that is, obesity and 
increased concentrations of estrogen hormones are a 
risk factor for developing malignancy of the 
endometrium, then both groups of subjects are at 
increased risk of endometrial cancer. 
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